Greenebaum Cancer Center - Clinical Trials

  Clinical Trials...
     More About Clinical Trials
     Participating
     Questions to Ask
     For More Information
  Research
  Cancer Overviews
  Treatment Programs
  Physicians and Staff

Current Clinical Trials for Stem Cell Transplant

GCC 0562-B - Filgrastim-Mobilized Peripheral Blood Stem Cells for Allogeneic Transplantation with Unrelated Donors

GCC 0831 - Evaluation of Efficacy and Mechanisms of an Anti-Inflammatory Intervention for Chemotherapy Related Mucosal Injury

GCC 0851 - Phase II Trial of Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation for Patients with Relapsed Follicular Non-Hodgkin's Lymphoma Beyond First Complete Response. BMT/CTN 0701

GCC 0911 - Study of Fludarabine Based Conditioning for Allogeneic Stem Cell Transplantation for Myelofibrosis

GCC:0628 - A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Prophylactic Use of Maribavir for the Prevention of Cytomegalovirus Disease in Recipients of Allogeneic Stem Cell Transplants.



Email this Page                                                                     Print this Page

Home Site Map Disclaimer University of Maryland Greenebaum Cancer Center UM School of Medicine UM Medical System UM Medical Center Text: If you would like to make an appointment or talk to someone about our services please call 1-800-888-8823. Physicians can call our dedicated consultation referral service at 1-800-373-4111.